Compared to voriconazole, liposomal amphotericin B plus caspofungin also showed a trend in reducing mortality (RR, 0.19; 95% CI, 0.01–3.80), but the difference is not significant.
← all excerpts
Compare the efficacy of antifungal agents as primary therapy for invasive aspergillosis: a network meta-analysis.
1
—
—